ARS Pharmaceuticals, Inc. (SPRY) Shareholders Equity

Annual Shareholders Equity:

$256.80M+$26.04M(+11.28%)
December 31, 2024

Summary

  • As of today, SPRY annual stockholders equity is $256.80 million, with the most recent change of +$26.04 million (+11.28%) on December 31, 2024.
  • During the last 3 years, SPRY annual shareholders equity has risen by +$212.03 million (+473.59%).
  • SPRY annual shareholders equity is now -32.93% below its all-time high of $382.88 million, reached on December 1, 2020.

Performance

SPRY Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Quarterly Shareholders Equity:

$147.66M-$44.67M(-23.22%)
September 30, 2025

Summary

  • As of today, SPRY quarterly stockholders equity is $147.66 million, with the most recent change of -$44.67 million (-23.22%) on September 30, 2025.
  • Over the past year, SPRY quarterly shareholders equity has dropped by -$53.32 million (-26.53%).
  • SPRY quarterly shareholders equity is now -61.44% below its all-time high of $382.88 million, reached on December 1, 2020.

Performance

SPRY Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSPRYbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

SPRY Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+11.3%-26.5%
3Y3 Years+473.6%-44.7%
5Y5 Years+4683.2%-61.4%

SPRY Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-5.9%+473.6%-44.7%at low
5Y5-Year-32.9%+473.6%-61.4%at low
All-TimeAll-Time-32.9%+4683.2%-61.4%+2735.3%

SPRY Shareholders Equity History

DateAnnualQuarterly
Sep 2025
-
$147.66M(-23.2%)
Jun 2025
-
$192.32M(-16.0%)
Mar 2025
-
$228.97M(-10.8%)
Dec 2024
$256.80M(+11.3%)
$256.80M(+27.8%)
Sep 2024
-
$200.98M(-6.6%)
Jun 2024
-
$215.24M(-3.9%)
Mar 2024
-
$223.87M(-3.0%)
Dec 2023
$230.76M(-15.4%)
$230.76M(-2.7%)
Sep 2023
-
$237.28M(-4.5%)
Jun 2023
-
$248.55M(-4.8%)
Mar 2023
-
$261.15M
DateAnnualQuarterly
Dec 2022
$272.89M(+509.5%)
-
Sep 2022
-
$267.07M(-4.2%)
Jun 2022
-
$278.79M(-4.9%)
Mar 2022
-
$293.23M(-6.6%)
Dec 2021
$44.77M(-88.3%)
-
Dec 2021
-
$313.81M(-5.5%)
Sep 2021
-
$332.13M(-5.0%)
Jun 2021
-
$349.65M(-5.1%)
Mar 2021
-
$368.55M(-3.7%)
Dec 2020
$382.88M(+6933.4%)
$382.88M(+6933.4%)
Dec 2019
-$5.60M(-130.8%)
-$5.60M
Dec 2018
$18.20M
-

FAQ

  • What is ARS Pharmaceuticals, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. annual shareholders equity year-on-year change?
  • What is ARS Pharmaceuticals, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for ARS Pharmaceuticals, Inc.?
  • What is ARS Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

What is ARS Pharmaceuticals, Inc. annual stockholders equity?

The current annual shareholders equity of SPRY is $256.80M

What is the all-time high annual shareholders equity for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high annual stockholders equity is $382.88M

What is ARS Pharmaceuticals, Inc. annual shareholders equity year-on-year change?

Over the past year, SPRY annual stockholders equity has changed by +$26.04M (+11.28%)

What is ARS Pharmaceuticals, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of SPRY is $147.66M

What is the all-time high quarterly shareholders equity for ARS Pharmaceuticals, Inc.?

ARS Pharmaceuticals, Inc. all-time high quarterly stockholders equity is $382.88M

What is ARS Pharmaceuticals, Inc. quarterly shareholders equity year-on-year change?

Over the past year, SPRY quarterly stockholders equity has changed by -$53.32M (-26.53%)
On this page